|
|||||
|
|
The costs of treating and not treating patients with chronic myeloid leukemia with tyrosine kinase inhibitors among Medicare patients in the United States |
|
| Authors: | Erlene K. Seymour MD Julie J. Ruterbusch MPH Aaron N. Winn PhD Julie A. George MS Jennifer L. Beebe-Dimmer PhD MPH Charles A. Schiffer MD |
| Affiliation: | 1. Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan;2. Department of Clinical Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin |
| Abstract: | |
| Keywords: | chronic myeloid leukemia (CML) cost cost-sharing subsidies tyrosine kinase inhibitors |